Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-22-011778)

Filing Details

Accession Number:: 0001415889-22-011778
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-28 07:42:26
Reporting Period:: 2022-11-25

Accepted Time:: 2022-11-28 07:42:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1719406	Nrx Pharmaceuticals Inc.	NRXP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1284934	Seth Voorhees Van	C/O Nrx Pharmaceuticals Inc 1201 N. Market Street, Suite 111 Wilmington DE 19801	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2022-11-25	8,716	$1.12	8,716	No	4	P	Indirect	Shares purchased though 401(k) plan
Common Stock, Par Value $0.001 Per Share	Acquisiton	2022-11-25	600	$1.10	9,316	No	4	P	Indirect	Shares purchased though 401(k) plan
Common Stock, Par Value $0.001 Per Share	Acquisiton	2022-11-25	7,021	$1.11	16,377	No	4	P	Indirect	Shares purchased though 401(k) plan

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Shares purchased though 401(k) plan
No	4	P	Indirect	Shares purchased though 401(k) plan
No	4	P	Indirect	Shares purchased though 401(k) plan